Searched for
GSK BATTLE
XDefiant Season 1: See details about release date, new maps and Capture the Flag modeXDefiant Season 1 launches on July 2, 2024, introducing new maps, a GSK Faction, a 90-tier Battle Pass and Ranked Play. This season continu...- Self-care products set to grow big; no downtrading in healthcare, says Haleon CEOAccording to Brian McNamara, the global CEO of consumer healthcare company Haleon, the focus on preventive healthcare post-pandemic is crea...
- GSK Velu in talks with investors, PEs & banking firms to buy Metropolis Healthcare stakeMetropolis chief executive Ameera Shah and her family has initiated a formal process to sell part of the promoter stake and is understood t...
- Unilever's strategy in spotlight after dropping $68 billion GSK battleShares in Unilever, the maker of a range of brands such as Dove soap and Hellmann's mayonnaise, gained 2% after the company said late on We...
- Bharat Biotech to produce world's 1st malaria vaccine approved by WHOEarlier, WHO endorsed the world's first malaria vaccine and said it should be given to children across Africa in the hope that it will spur...
- Hindustan Unilever ropes in Akshay Kumar for HorlicksHorlicks has over half the malted beverages market in India, and was acquired to help HUL’s focus in building a profitable and sustainable ...
- With $3.4B cash bid, Unilever may bag GSK’s nutrition businessThe deal, if finalised, will strengthen Unilever’s position in India, its most important emerging market.
- Glaxo wins battle for GSK trademarkThe high court first passed an ex-parte ad-interim injunction restraining the Indian 'GSK' from infringing on a trademark registered to the...
- Kal Sundaram set for return to Sun PharmaSundaram had moved to the US after serving as CEO of Sun Pharma till 2012. Taro Pharmaceuticals said its board will appoint a CEO to solely...
- Taro boss Kal Sundaram set to take up India role at Sun PharmaDilip Shanghvi, chairman of Taro board credited Kal Sundaram for providing significant leadership “over a challenging period for both the c...
- Corporate ethics: Why companies should beware of internal fraudCompanies must take multiple precautions to inoculate themselves against the risk of employee fraud. To start with, ensure the basics are i...
- Novartis India vice-chairman & managing director, Ranjit Shahani says company now focuses on new products, business growthNovartis India has over the past year launched three successful patented drugs and over 12 generic drugs that have helped it expand its pre...
- GSK, PepsiCo, Godrej hit e-way, launching products online firstBeverage and snacks maker PepsiCo, too, has allocated 20% of its big-ticket advertising campaign around the IPL tournament on digital media.
- FMCG battle for shelf space moves onlineGlaxoSmithKline, PepsiCo, Mondelez, Marico are doubling digital spends or launching online first to reach their target audience faster.
- Local investors should hold on to their Hindustan Unilever sharesNet sales and market capitalisation have doubled in the last six years while the stock price has trebled in the last five years.
- HUL and Nestle to battle it out for share of Rs 200-crore oats marketHindustan Unilever and Nestle plan to launch oats under Knorr and Maggi brands, respectively, as healthy extensions of their noodle segment...
- Cipla opposes patent for GSK’s cancer drugCipla has filed a grant opposition in the Kolkata patent office against GSK's newly-launched breast cancer drug on grounds of obviousness a...
- Horlicks, Complan slug it out over price pointsA no-holds-barred legal battle has now broken out between GlaxoSmithKline and Heinz India - in the Bombay and Delhi high courts over their ...
- Indian generic companies may tread Ranbaxy pathRanbaxy's patent settlement with Pfizer may lead more Indian generic cos to go for out-of-court settlements with their innovator counterpar...
- Innovators coming to terms with hawkish generic drug makersHaving emerged as a gold mine for Indian pharmaceutical companies in recent years, the drugs market in the United States is now reeling und...
Load More
